MMP-MEL18-372
Phase 1B/2 Study of PAC-1 and Entrectinib for Patients with Metastatic Uveal Melanoma
Status: Closed to Accrual
Learn more:
- clinicaltrials.gov: #NCT04589832
Study Contact: studies@hoosiercancer.org; (317) 921-2050.
Phase 1B/2 Study of PAC-1 and Entrectinib for Patients with Metastatic Uveal Melanoma
Status: Closed to Accrual
Learn more:
Study Contact: studies@hoosiercancer.org; (317) 921-2050.
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter